These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26851596)

  • 1. A role for Toll-like receptor 4 in the host response to the lung infection of Yersinia pseudotuberculosis in mice.
    Choi JA; Jeong YJ; Kim JE; Kang MJ; Kim JC; Oh SM; Lee KB; Kim DH; Kim DJ; Park JH
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():54-60. PubMed ID: 26851596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response.
    Wang X; Hao X; Yang Y; Jia S; Chen Y; Yang W; Luo Y; Xie Z; Gu Y; Wu Y; Zhang F; Li M; Wang Y; Shen X; Xu L
    Vet Microbiol; 2024 Oct; 297():110194. PubMed ID: 39084162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
    Zhang Y; Bliska JB
    Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
    Hudson KJ; Bouton AH
    Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.
    Porte R; Van Maele L; Muñoz-Wolf N; Foligné B; Dumoutier L; Tabareau J; Cayet D; Gosset P; Jonckheere N; Van Seuningen I; Chabalgoity JA; Simonet M; Lamkanfi M; Renauld JC; Sirard JC; Carnoy C
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection.
    Paczosa MK; Fisher ML; Maldonado-Arocho FJ; Mecsas J
    Cell Microbiol; 2014 Feb; 16(2):247-68. PubMed ID: 24119087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphogenesis of Experimental Infection Caused by Plasmid Variants of Yersinia pseudotuberculosis.
    Somova LM; Drobot EI; Plekhova NG; Lyapun IN; Shubin FN
    Bull Exp Biol Med; 2016 Dec; 162(2):264-268. PubMed ID: 27905039
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Schachterle JK; Stewart RM; Schachterle MB; Calder JT; Kang H; Prince JT; Erickson DL
    Front Cell Infect Microbiol; 2018; 8():323. PubMed ID: 30280093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia.
    Balada-Llasat JM; Panilaitis B; Kaplan D; Mecsas J
    Vaccine; 2007 Feb; 25(8):1526-33. PubMed ID: 17194509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
    Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
    PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.
    Auerbuch V; Isberg RR
    Infect Immun; 2007 Jul; 75(7):3561-70. PubMed ID: 17420232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
    Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J
    Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
    Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
    PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.
    Shaban L; Nguyen GT; Mecsas-Faxon BD; Swanson KD; Tan S; Mecsas J
    PLoS Pathog; 2020 May; 16(5):e1008576. PubMed ID: 32392230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
    Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
    Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization of Th1/Th2 cytokine responses to experimental Yersinia pseudotuberculosis infection in cats.
    Sukura A; Higgins J; Pedersen NC
    Vet Immunol Immunopathol; 1998 Oct; 65(2-4):139-50. PubMed ID: 9839869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.